Trial Outcomes & Findings for Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults (NCT NCT03863353)

NCT ID: NCT03863353

Last Updated: 2022-04-06

Results Overview

Perceived riskiness of opioid misuse (0-40 where 40 indicates highest risk perception)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

503 participants

Primary outcome timeframe

Baseline, day 14, 3 months post intervention

Results posted on

2022-04-06

Participant Flow

Subjects recruited from 11/2019 through May 2021 from surgical clinic rosters at University of Michigan

Enrollment number includes all who "Started" by signing the consent and were assigned to study groups. "Completed" indicates those who were analyzed. "Not completed includes those withdrawn after signing consent but prior to analyses. Reasons incomplete are indicated below (reasons included; alterations in surgical procedure or no opioid prescription dispensed).

Participant milestones

Participant milestones
Measure
Education Intervention
This group will receive the scenario-tailored STOMP educational feedback Educational Intervention: This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Control
This group will receive only standard of care information.
Overall Study
STARTED
282
221
Overall Study
COMPLETED
258
201
Overall Study
NOT COMPLETED
24
20

Reasons for withdrawal

Reasons for withdrawal
Measure
Education Intervention
This group will receive the scenario-tailored STOMP educational feedback Educational Intervention: This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Control
This group will receive only standard of care information.
Overall Study
incomplete baseline; surgical complication; no opioid prescription
24
20

Baseline Characteristics

Scenario Tailored Opioid Messaging Program (STOMP) to Improve Risk Understanding in Young Adults

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Education Intervention
n=258 Participants
This group will receive the scenario-tailored STOMP educational feedback Educational Intervention: This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Control
n=201 Participants
This group will receive only standard of care information.
Total
n=459 Participants
Total of all reporting groups
Age, Continuous
19.1 years
STANDARD_DEVIATION 2.7 • n=5 Participants
19.1 years
STANDARD_DEVIATION 2.8 • n=7 Participants
19.1 years
STANDARD_DEVIATION 2.7 • n=5 Participants
Sex: Female, Male
Female
134 Participants
n=5 Participants
104 Participants
n=7 Participants
238 Participants
n=5 Participants
Sex: Female, Male
Male
124 Participants
n=5 Participants
97 Participants
n=7 Participants
221 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
16 Participants
n=5 Participants
7 Participants
n=7 Participants
23 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
242 Participants
n=5 Participants
194 Participants
n=7 Participants
436 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants
n=5 Participants
3 Participants
n=7 Participants
5 Participants
n=5 Participants
Race (NIH/OMB)
Asian
16 Participants
n=5 Participants
15 Participants
n=7 Participants
31 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
22 Participants
n=5 Participants
13 Participants
n=7 Participants
35 Participants
n=5 Participants
Race (NIH/OMB)
White
207 Participants
n=5 Participants
163 Participants
n=7 Participants
370 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
11 Participants
n=5 Participants
7 Participants
n=7 Participants
18 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants

PRIMARY outcome

Timeframe: Baseline, day 14, 3 months post intervention

Population: All who completed at least one follow-up measurement of risk perception.

Perceived riskiness of opioid misuse (0-40 where 40 indicates highest risk perception)

Outcome measures

Outcome measures
Measure
Education Intervention
n=258 Participants
This group will receive the scenario-tailored STOMP educational feedback Educational Intervention: This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Control
n=201 Participants
This group will receive only standard of care information.
Opioid Risk Perception
Month 3
31.0 score on a scale
Standard Deviation .62
29.8 score on a scale
Standard Deviation 1.21
Opioid Risk Perception
Baseline
31.4 score on a scale
Standard Deviation 0.85
31.1 score on a scale
Standard Deviation 1.01
Opioid Risk Perception
Day 14
32.8 score on a scale
Standard Deviation .65
30.02 score on a scale
Standard Deviation 1.12

SECONDARY outcome

Timeframe: 3 months post intervention

Population: Rest of the sample lost to follow-up at months 1-3

Number of participants with opioid misuse intentions and behaviors

Outcome measures

Outcome measures
Measure
Education Intervention
n=226 Participants
This group will receive the scenario-tailored STOMP educational feedback Educational Intervention: This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Control
n=173 Participants
This group will receive only standard of care information.
Opioid Misuse Intention Decisions
Misuse Intentions
47 Participants
38 Participants
Opioid Misuse Intention Decisions
Misuse behavior
18 Participants
12 Participants

Adverse Events

Education Intervention

Serious events: 9 serious events
Other events: 0 other events
Deaths: 0 deaths

Control

Serious events: 6 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Education Intervention
n=258 participants at risk
This group will receive the scenario-tailored STOMP educational feedback Educational Intervention: This intervention provides scenario-tailored opioid risk message feedback immediately following interactive analgesic decision-making exercises.
Control
n=201 participants at risk
This group will receive only standard of care information.
Surgical and medical procedures
Hospitalization
3.5%
9/258 • Number of events 9 • 3 months
Review of medical records, clinic visits etc.
3.0%
6/201 • Number of events 6 • 3 months
Review of medical records, clinic visits etc.

Other adverse events

Adverse event data not reported

Additional Information

Dr. Terri Voepel-Lewis

University of Michigan

Phone: 734-6466803

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place